Low-dose-rate radiation attenuates the response of the tumor suppressor TP53

Radiation Research

Volumn 151, Issue 3, 1999, Pages 368-372

  Ohnishi, Takeo ^a   Wang, Xinjiang ^a,c   Takahashi, Akihisa ^a   Ohnishi, Ken ^a   Ejima, Yosuke ^b  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN P53;

ARTICLE; CONTROLLED STUDY; GAMMA IRRADIATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RADIATION DOSE; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

EID: 0033009821     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.2307/3579950     Document Type: Article

References (21)

1. T. Sugahara, Radiation paradigm and its shift. J. Radiat. Res. 35, 48-52 (1994).
2. Z. Wang, J. D. Boice, L. Wei, G. W. Beebe, Y. Zha, M. M. Kaplan, Z. Tao, H. R. Maxon, S. Zhan and D. Preston, Thyroid nodularity and chromosome aberrations among women in area of high background radiation in China. J. Natl. Cancer Inst. 82, 478-485 (1990).
3. M. Mifune, T. Sobue, H. Arimoto, Y. Komoto, S. Kondo and H. Tanooka, Cancer mortality survey in a spa area (Misasa, Japan) with a high radon background. Jpn. J. Cancer Res. 83, 1-5 (1992).
4. T. M. Gottlieb and M. Oren, p53 in growth control and neoplasia. Biochim. Biophys. Acta 1287, 77-102 (1996).
5. M. Kastan, Q. Zhan, W. el-Deiry, F. Carrier, T. Jacks, W. Walsh, B. Plunkett, B. Vogelstein and A. Fornace, Jr., A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71, 587-597 (1992).
6. 1 arrest. Cell 76, 1013-1023 (1994).
7. 2/M and the cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc. Natl. Acad. Sci. USA 92, 8493-8497 (1995).
8. W. S. el-Deiry, T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler and B. Vogelstein, WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825 (1993).
9. 1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol. Cell. Biol. 14, 6264-6277 (1994).
10. 1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. Genes Dev. 10, 934-947 (1996).
11. T. Ohnishi, X. Wang, K. Ohnishi, H. Matsumoto and A. Takahashi, p53-dependent induction of WAF1 by heat treatment in human glioblastoma cells. J. Biol. Chem. 271, 14510-14513 (1996).
12. X. Wang and T. Ohnishi, p53-dependent signal transduction induced by stress. J. Radiat. Res. 38, 179-194 (1997).
13. X. Wang, H. Matsumoto, K. Okaichi and T. Ohnishi, p53 accumulation in various organs of rats after whole-body exposure to low-dose X-ray irradiation. Anticancer Res. 16, 1671-1674 (1996).
14. X. Wang, A. Takahashi, K. Ohnishi, H. Matsumoto, K. Suda and T. Ohnishi, Bifunctional effects of a protein kinase inhibitor (H-7) on heat-induced p53-dependent WAF1 accumulation. Exp. Cell Res. 237, 186-191 (1997).
15. Y. Haupt, S. Rowan, E. Shaulian, K. H. Vousden and M. Oren, Induction of apoptosis in HeLa cells by trans-activation deficient p53. Genes Dev. 9, 2170-2183 (1995).
16. K. Ohnishi, X. Wang, A. Takahashi and T. Ohnishi, Contribution of protein kinase C to p53-dependent WAF1 induction pathway after heat treatment in human glioblastoma cell lines. Exp. Cell Res. 238, 399-406 (1998).
17. I. Takenaka, F. Morin, B. R. Seizinger and N. Kley, Regulation of the sequence-specific DNA binding function of p53 by protein kinase C and protein phosphatases. J. Biol Chem. 270, 5405-5411 (1995).
18. S. Wolff, Aspects of the adaptive response to very low doses of radiation and other agents. Mutat. Res. 358, 135-142 (1996).
19. C. K. Hill, F. M. Buonaguro, C. P. Myers, A. Han and M. M. Elkind, Fission-spectrum neutrons at reduced dose rate enhance neoplastic transformation. Nature 298, 67-68 (1982).
20. D. Lane, p53, guardian of the genome. Nature 358, 15-16 (1992). [News]
21. M. S. Sasaki, Radioadaptive response: An implication for the biological consequences of low dose-rate exposure to radiations. Mutat. Res. 358, 207-213 (1996).